AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11489711 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrodiagnostic testing using pudendal somatosensory evoked potentials and bulbocavernosus reflex latency measurements in 14 patients with CPPS.
Number of subjects: 45
Study 11489711 — intervention group
Group type: COMPARATOR
Intervention: Thermal sensory analysis testing on the perineum and anterior thigh using noxious heat stimuli in 31 patients with CPPS and 14 controls.
Number of subjects: 45
Study 9507413 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral artery stenosis
Number of subjects: 47
Study 9507413 — intervention group
Group type: COMPARATOR
Intervention: No cerebral artery stenosis
Number of subjects: 47
Study 9507413 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and presence of arterial stenosis
Number of subjects: 47
Study 9507413 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal cerebral signs
Number of subjects: 47
Study 9507413 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasgow Outcome Scale (GOS)
Number of subjects: 47
Study 7995011 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin (intravenous infusion during the first 24 hours, then 10 mg/day transdermal)
Number of subjects: 1526
Study 7995011 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril (5 then 10 mg/day)
Number of subjects: 1526
Study 7995011 — intervention group
Group type: COMPARATOR
Intervention: Control (neither intervention)
Number of subjects: 1526
Study 7995011 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 1526
Study 30588836 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol and Vitamin E
Number of subjects: 80
Study 30588836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 28104096 — intervention group
Group type: EXPERIMENTAL
Intervention: U‐Healthcare intervention (Internet‐based integrated management)
Number of subjects: 212
Study 28104096 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical treatment (control group)
Number of subjects: 212
Study 26031346 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety and Negative Urgency
Number of subjects: 193
Study 23828228 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (n=30) for 16 weeks
Number of subjects: 60
Study 23828228 — intervention group
Group type: COMPARATOR
Intervention: Decapeptyl (n=30) every 4 weeks for 4 doses
Number of subjects: 60
Study 22212269 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (EG)
Number of subjects: 30
Study 22212269 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study 19558539 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 331
Study 19558539 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 331
Study 16397162 — intervention group
Group type: EXPERIMENTAL
Intervention: TAAG intervention designed to be appropriate for both sexes, addressing girls' stated preferences and barriers for physical activity.
Number of subjects: 0
Study 15456517 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotic preparation (Ecologic 641) administered twice daily through a nasojejunal tube for 28 days or until discharge.
Number of subjects: 200
Study 15456517 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered twice daily through a nasojejunal tube for 28 days or until discharge.
Number of subjects: 200
Study 15456517 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotic preparation (Ecologic 641)
Number of subjects: 200
Study 15456517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 10786739 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with 8 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 50
Study 10786739 — intervention group
Group type: COMPARATOR
Intervention: Combined sciatic‐femoral nerve block with 25 ml of mepivacaine 20 mg ml(‐1)
Number of subjects: 50
Study 9310807 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 81
Study 9310807 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 81
Study 8362808 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 0
Study 8362808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3527523 — intervention group
Group type: EXPERIMENTAL
Intervention: Human ultralente insulin
Number of subjects: 6
Study 3527523 — intervention group
Group type: COMPARATOR
Intervention: Porcine lente insulin
Number of subjects: 6
Study 29940921 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted cognitive‐behavioral stress management (CBSM) course delivered via WeChat for 3 months, including motivation for physical activities.
Number of subjects: 300
Study 29940921 — intervention group
Group type: COMPARATOR
Intervention: Brochure on nutrition for PLWH plus standard care (control group).
Number of subjects: 300
Study 27428746 — intervention group
Group type: EXPERIMENTAL
Intervention: Children infected with HIV in utero (IU)
Number of subjects: 13647
Study 27428746 — intervention group
Group type: EXPERIMENTAL
Intervention: Children infected with HIV intrapartum (IP)
Number of subjects: 13647
Study 27428746 — intervention group
Group type: EXPERIMENTAL
Intervention: Children infected with HIV postnatally (PN)
Number of subjects: 13647
Study 27428746 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-exposed uninfected (HEU) children
Number of subjects: 13647
Study 27428746 — intervention group
Group type: COMPARATOR
Intervention: HIV-unexposed children
Number of subjects: 13647
Study 24302269 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) patients with left atrial enlargement and reduced LAEF
Number of subjects: 971
Study 24302269 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing electrical burden of AF and higher CHADS2 scores
Number of subjects: 971
Study 24302269 — intervention group
Group type: EXPERIMENTAL
Intervention: AF subjects with normal LA size
Number of subjects: 971
Study 24302269 — intervention group
Group type: EXPERIMENTAL
Intervention: AF subjects in sinus rhythm at echocardiography
Number of subjects: 971
Study 22856338 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 cm wide elastic cuff
Number of subjects: 27
Study 22856338 — intervention group
Group type: EXPERIMENTAL
Intervention: 13.5 cm wide non-elastic cuff
Number of subjects: 27
Study 22856338 — intervention group
Group type: COMPARATOR
Intervention: BFR exercise (both cuffs)
Number of subjects: 27
Study 19887763 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise and diet intervention
Number of subjects: 1410
Study 18605455 — intervention group
Group type: EXPERIMENTAL
Intervention: Fu Fang Ya Tong Ding
Number of subjects: 120
Study 18605455 — intervention group
Group type: COMPARATOR
Intervention: iodine glycerol
Number of subjects: 120
Study 18605455 — intervention group
Group type: COMPARATOR
Intervention: routine rinsing treatment (negative group)
Number of subjects: 120
Study 15794740 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 0
Study 15794740 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study 15794740 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of valsartan and captopril
Number of subjects: 0
Study 12492913 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials in periodontal research (RCT-Ps)
Number of subjects: 675
Study 12492913 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Trials in periodontal research (CT-Ps)
Number of subjects: 675
Study 12492913 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-Ps covering periodontal surgery and gingivitis/plaque treatment or prevention
Number of subjects: 675
Study 12492913 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-Ps published in two different journals
Number of subjects: 675
Study 12492913 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-Ps from the U.S.A
Number of subjects: 675
Study 10406339 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO2) insufflation
Number of subjects: 100
Study 10406339 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 100
Study 7584752 — intervention group
Group type: EXPERIMENTAL
Intervention: Padded long spine board
Number of subjects: 30
Study 7584752 — intervention group
Group type: COMPARATOR
Intervention: Unpadded long spine board
Number of subjects: 30
Study 2371814 — intervention group
Group type: EXPERIMENTAL
Intervention: Goretex reconstruction
Number of subjects: 41
Study 2371814 — intervention group
Group type: COMPARATOR
Intervention: Kennedy Ligament Augmentation Device (LAD)
Number of subjects: 41
Study 7015842 — intervention group
Group type: EXPERIMENTAL
Intervention: coherin
Number of subjects: 10
Study 7015842 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 31612193 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 80
Study 28434871 — intervention group
Group type: EXPERIMENTAL
Intervention: Volitional helpsheet (VHS) plus usual treatment
Number of subjects: 518
Study 28434871 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 518
Study 27198953 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvorexant (20/15 mg and 40/30 mg)
Number of subjects: 1482
Study 27198953 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvorexant
Number of subjects: 1482
Study 27198953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1482
Study 24442244 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus autologous stem cell transplant (ASCT)
Number of subjects: 96
Study 24442244 — intervention group
Group type: COMPARATOR
Intervention: Rituximab, fludarabine, and cyclophosphamide (R-FC)
Number of subjects: 96
Study 24442244 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus ASCT
Number of subjects: 96
Study 24442244 — intervention group
Group type: COMPARATOR
Intervention: R-FC
Number of subjects: 96
Study 21705921 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional stabilization training (8 weeks)
Number of subjects: 28
Study 21705921 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physical training)
Number of subjects: 28
Study 19335882 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical wound treatment
Number of subjects: 338
Study 19335882 — intervention group
Group type: EXPERIMENTAL
Intervention: Exponential model of wound healing
Number of subjects: 338
Study 17334274 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (10 mg twice daily)
Number of subjects: 0
Study 17334274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17334274 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 0
Study 14722673 — intervention group
Group type: EXPERIMENTAL
Intervention: id (99m)Tc-HIG
Number of subjects: 12
Study 14722673 — intervention group
Group type: COMPARATOR
Intervention: sc (99m)Tc-HIG
Number of subjects: 12
Study 14722673 — intervention group
Group type: EXPERIMENTAL
Intervention: id (99m)Tc-nanocolloid
Number of subjects: 12
Study 14722673 — intervention group
Group type: COMPARATOR
Intervention: sc (99m)Tc-nanocolloid
Number of subjects: 12
Study 11408386 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine once daily
Number of subjects: 201
Study 11408386 — intervention group
Group type: COMPARATOR
Intervention: Co-amilozide (hydrochlorothiazide 25 mg, amiloride 2.5 mg)
Number of subjects: 201
Study 9431484 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulation of the vagus afferent endings (ENS)
Number of subjects: 10
Study 9431484 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ENS)
Number of subjects: 10
Study 8231842 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL3 cholesterol level
Number of subjects: 74
Study 8231842 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL3 cholesterol level
Number of subjects: 74
Study 8231842 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL3 cholesterol level < 1.8 mmol/L
Number of subjects: 74
Study 3305591 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 225
Study 3305591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study 29737068 — intervention group
Group type: EXPERIMENTAL
Intervention: Low concentration contrast agent combined double low dose (80 kV, 15 mL, 320 mg I/mL)
Number of subjects: 60
Study 29737068 — intervention group
Group type: COMPARATOR
Intervention: Control group (120 kV, 50 mL, 370 mg I/mL)
Number of subjects: 60
Study 27352490 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold hook fishing acupuncture
Number of subjects: 60
Study 27352490 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 60
Study 24996524 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SMO) for 10 days
Number of subjects: 126
Study 24996524 — intervention group
Group type: COMPARATOR
Intervention: Oxazepam for 10 days
Number of subjects: 126
Study 24996524 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SMO)
Number of subjects: 126
Study 24996524 — intervention group
Group type: COMPARATOR
Intervention: Oxazepam
Number of subjects: 126
Study 21861080 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular coiling for ruptured cerebral aneurysms
Number of subjects: 129
Study 21861080 — intervention group
Group type: EXPERIMENTAL
Intervention: Dome size ≥7.5 mm
Number of subjects: 129
Study 21861080 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment aneurysm re-rupture
Number of subjects: 129
Study 21861080 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-small size/small neck aneurysm (dome size ≥10 mm or neck size ≥4 mm)
Number of subjects: 129
Study 21861080 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual aneurysms on immediate post-coiling angiograms
Number of subjects: 129
Study 20214061 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced muscular tension needling method
Number of subjects: 106
Study 20214061 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture method
Number of subjects: 106
Study 16965889 — intervention group
Group type: EXPERIMENTAL
Intervention: GOES treatment
Number of subjects: 103
Study 16965889 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 103
Study 16238662 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for child only
Number of subjects: 71
Study 16238662 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for child and parent
Number of subjects: 71
Study 16238662 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 71
Study 11855379 — intervention group
Group type: EXPERIMENTAL
Intervention: Back pain patients during left axial rotation exertion
Number of subjects: 24
Study 11855379 — intervention group
Group type: EXPERIMENTAL
Intervention: Back pain patients during right axial rotation exertion
Number of subjects: 24
Study 11855379 — intervention group
Group type: COMPARATOR
Intervention: Matched controls during axial rotation exertion
Number of subjects: 24
Study 10885864 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine 10 mg per day
Number of subjects: 166
Study 10885864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study 8625152 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cisplatin-based chemotherapy and radiotherapy
Number of subjects: 1887
Study 8625152 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined noncisplatin-based chemotherapy and radiotherapy
Number of subjects: 1887
Study 8625152 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 1887
Study 1689558 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HES 450,000/0.7
Number of subjects: 60
Study 1689558 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% HES 200,000/0.5
Number of subjects: 60
Study 1689558 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% HES 200,000/0.5
Number of subjects: 60
Study 1689558 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HES 40,000/0.5
Number of subjects: 60
Study 1689558 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HES 200,000/0.5
Number of subjects: 60
Study 1689558 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HES 200,000/0.62
Number of subjects: 60
Study 1689558 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60
Study 6928739 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic force application
Number of subjects: 17
Study 6928739 — intervention group
Group type: COMPARATOR
Intervention: Control (no orthodontic force)
Number of subjects: 17
Study 31377702 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor training for 3 months
Number of subjects: 60
Study 31377702 — intervention group
Group type: COMPARATOR
Intervention: Cognitive control training for 3 months
Number of subjects: 60
Study 31377702 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor training
Number of subjects: 60
Study 31377702 — intervention group
Group type: COMPARATOR
Intervention: Cognitive control training
Number of subjects: 60
Study 27747986 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA supplementation (0.64% ARA and various concentrations of DHA: 0.32%, 0.64%, or 0.96%)
Number of subjects: 69
Study 27747986 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LCPUFA)
Number of subjects: 69
Study 27747986 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA supplementation
Number of subjects: 69
Study 26371404 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week exercise intervention
Number of subjects: 135
Study 26371404 — intervention group
Group type: COMPARATOR
Intervention: Health education control group
Number of subjects: 135
Study 23758126 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring
Number of subjects: 60
Study 23758126 — intervention group
Group type: COMPARATOR
Intervention: Self-monitored plasma glucose (control)
Number of subjects: 60
Study 21718999 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepraspray Adhesion Barrier (n = 21)
Number of subjects: 41
Study 21718999 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 41
Study 19121772 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 0
Study 19121772 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet with 50 mmol/day sodium intake
Number of subjects: 0
Study 19121772 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction‐plus‐weight loss
Number of subjects: 0
Study 19121772 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 0
Study 19121772 — intervention group
Group type: COMPARATOR
Intervention: Reduced dietary sodium intake
Number of subjects: 0
Study 17523995 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored smoking cessation advice letters
Number of subjects: 1508
Study 17523995 — intervention group
Group type: COMPARATOR
Intervention: Usual care (telephone counselling and an information pack)
Number of subjects: 1508
Study 14668568 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily lisinopril (5-20 mg/d)
Number of subjects: 32
Study 14668568 — intervention group
Group type: COMPARATOR
Intervention: Once-daily lisinopril (5-20 mg/d)
Number of subjects: 32
Study 11181127 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month short-course therapy for tuberculosis including rifampin
Number of subjects: 6
Study 11181127 — intervention group
Group type: COMPARATOR
Intervention: 6-month short-course therapy for tuberculosis without HIV infection
Number of subjects: 6
Study 9833167 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (antihypertensive drug)
Number of subjects: 500
Study 9833167 — intervention group
Group type: COMPARATOR
Intervention: Restrictive antihypertensive therapy (control)
Number of subjects: 500
Study 8058004 — intervention group
Group type: EXPERIMENTAL
Intervention: Escherichia coli L‐asparaginase
Number of subjects: 20
Study 8058004 — intervention group
Group type: EXPERIMENTAL
Intervention: Erwinia chrysanthemi L‐asparaginase
Number of subjects: 20
Study 8058004 — intervention group
Group type: COMPARATOR
Intervention: Both E. coli and Erwinia L‐asparaginase
Number of subjects: 20
Study 4004503 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy
Number of subjects: 9
Study 4004503 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral psychotherapy
Number of subjects: 9
Study 4004503 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug counseling
Number of subjects: 9
Study 4004503 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist personal qualities
Number of subjects: 9
Study 4004503 — intervention group
Group type: EXPERIMENTAL
Intervention: Helping Alliance Questionnaire (early-in-treatment measure)
Number of subjects: 9
Study 4004503 — intervention group
Group type: EXPERIMENTAL
Intervention: Purity of therapy techniques
Number of subjects: 9
Study 31403327 — intervention group
Group type: EXPERIMENTAL
Intervention: Measuring anticipated regret (AR) prior to intention
Number of subjects: 803
Study 31403327 — intervention group
Group type: COMPARATOR
Intervention: Measuring anticipated regret (AR) after intention
Number of subjects: 803
Study 31403327 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait reactance
Number of subjects: 803
Study 30010931 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical antifungal therapy
Number of subjects: 149
Study 30010931 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-emptive antifungal therapy
Number of subjects: 149
Study 25410474 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnoy's solution (CS)
Number of subjects: 50
Study 25410474 — intervention group
Group type: COMPARATOR
Intervention: 10% neutral buffered formalin (NBF)
Number of subjects: 50
Study 25410474 — intervention group
Group type: COMPARATOR
Intervention: Residual fat group (from NBF)
Number of subjects: 50
Study 25410474 — intervention group
Group type: COMPARATOR
Intervention: NBF and Retrospective groups
Number of subjects: 50
Study 23787221 — intervention group
Group type: EXPERIMENTAL
Intervention: Underbody warming system
Number of subjects: 110
Study 23787221 — intervention group
Group type: COMPARATOR
Intervention: Control group (no warming)
Number of subjects: 110
Study 22545821 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Enhancement/Cognitive Therapy (NECT)
Number of subjects: 39